Fitoterapia de la Medicina Tradicional China para combatir de forma exitosa la covid-19

Authors

Keywords:

covid-19, fitoterapia, fitoterapia china, Medicina Tradicional China

Abstract

Introducción: COVID-19 es una nueva enfermedad que se origina en China en noviembre del año 2019.  La enfermedad es producida por un tipo de coronavirus, identificado como Sars-Cov-2. Objetivo: describir el uso de la fitoterapia de la Medicina Tradicional China en el tratamiento de covid-19 en California durante 2020. Método: se realizó un estudio descriptivo de corte transversal con 50 pacientes del estado de California, tratados para el covid-19 con   fitoterapia de la Medicina Tradicional China. Se cumplió con los principios éticos y la confidencialidad de los datos. Se operacionalizaron variables que dieron salida al objetivo planteado. Se resumieron las variables con medidas de frecuencia absolutas y relativas, las cuales fueron representadas de forma tabular. Resultados: El 64% del grupo estudiado era masculino, de forma general predominó el grupo de 50-59 años. Al 58% se les realizó PCR y la totalidad dio positivo. Predominó la fiebre y el malestar general en más de la mitad de los pacientes estudiados. El factor de riesgo observado con mayor frecuencia fue el sobrepeso. El 80% tomó infusiones durante los síntomas, mientras que el 82% se recuperó en menos de una semana. Conclusiones: la endemia causada por el virus SARS-CoV sufrida en China entre los años 2 002 y 2 003 dio lugar a reportes sobre la eficacia de la MTC ancestral. Eso sirvió como base para combatir la pandemia causada por el SARS-CoV-2 en los pacientes tratados con esta terapia alternativa, lográndose resultados favorables.

Downloads

Download data is not yet available.

Author Biographies

Alland Meyer Letona, Portia Clinic

Bachelor of Science in Engineering Technology. Doctor of Acupuncture and Oriental Medicine. Master of Science in Traditional Chinese Medicine. Diplomate of Acupuncture and Oriental Medicine. Licencia de Acupunturista y Herbalista del Estado de California. Portia Clinic. Sunnyvale, California, Estados Unidos.

Miday Columbié Pileta, Facultad de Tecnología de la Salud. Universidad de Ciencias Médicas de La Habana

Doctora en Medicina. Especialista en Bioestadística. Máster en Atención Primaria de la Salud. Doctora en Ciencias de la Educación Médica. Profesora Asistente. Facultad de Tecnología de la Salud. Universidad de Ciencias Médicas de La Habana. La Habana, Cuba.

Arturo Rolando Piedrasanta, Centro Integral de Rehabilitación

Licenciado en Medicina Física y Rehabilitación. Magister Artium en Salud Laboral y Ambiente Ocupacional. Maestrante en Docencia Universitaria. Doctorado en Salud Mental y Dinámica Humana. Centro Integral de Rehabilitación. Ciudad Guatemala, Guatemala.

References

1. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. Who.int. [cited 2021 May 16]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
2. China releases genetic data on new coronavirus, now deadly [Internet]. Umn.edu. [cited 2021 May 16]. Available from: https://www.cidrap.umn.edu/news-perspective/2020/01/china-releases-genetic-data-new-coronavirus-now-deadly
3. Cdc.gov. [cited 2021 May 14]. Available from: https://www.cdc.gov/flu/symptoms/flu-vs-covid19.html
4. COVID-19 and gender monitor [Internet]. Unwomen.org. [cited 2021 May 15]. Available from: https://data.unwomen.org/resources/covid-19-and-gender-monitor
5. de Paz C, Muller M, Munoz Boudet AM, Gaddis I. Gender dimensions of the COVID-19 pandemic. World Bank, Washington, DC; 2020.
6. Coronavirus: the science explained-UKRI. Sex, gender and COVID-19 [Internet]. Ukri.org. [cited 2021 May 16]. Available from: https://coronavirusexplained.ukri.org/en/article/cad0007/
7. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–38.
8. Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: Focus on severity and mortality. Front Public Health. 2020;8:152.
9. Fda.gov. [cited 2021 May 15]. Available from: https://www.fda.gov/media/134922/download
10. Thevaccinereaction.org. [cited 2021 May 15]. Available from: https://thevaccinereaction.org/2020/11/understanding-pcr-tests-for-coronavirus/
11. 970Universal.com. [cited 2021 May 15]. Available from: https://970universal.com/2021/02/10/dr-sciuto-no-hay-forma-de-diferenciar-el-covid-19-de-un-resfrio/
12. Smith C. French coronavirus variant can’t be detected by PCR tests [Internet]. Bgr.com. BGR; 2021 [cited 2021 May 16]. Available from: https://bgr.com/tech/coronavirus-french-mutation-undetected-pcr-test-5913752/
13. Cdc.gov. [cited 2021 May 15]. Available from: https://www.cdc.gov/flu/symptoms/coldflu.html
14. Yang W, Chen X, Li Y, Guo S, Wang Z, Yu X. Advances in pharmacological activities of terpenoids. Nat Prod Commun. 2020;15(3):1934578X2090355.
15. Choudhry N, Zhao X, Xu D, Zanin M, Chen W, Yang Z, et al. Chinese therapeutic strategy for fighting COVID-19 and potential small-molecule inhibitors against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). J Med Chem. 2020;63(22):13205–27.
16. Boras B, Jones RM, Anson BJ, Arenson D, Aschenbrenner L, Bakowski MA, et al. Discovery of a novel inhibitor of Coronavirus 3CL protease as a clinical candidate for the potential treatment of COVID-19. bioRxivorg [Internet]. 2020; Available from: http://dx.doi.org/10.1101/2020.09.12.293498
17. Khalil AA, Rahman U ur, Khan MR, Sahar A, Mehmood T, Khan M. Essential oil eugenol: sources, extraction techniques and nutraceutical perspectives. RSC Adv. 2017;7(52):32669–81.
18. Huang M-Z, Yang Y-J, Liu X-W, Qin Z, Li J-Y. Aspirin eugenol ester attenuates oxidative injury of vascular endothelial cells by regulating NOS and Nrf2 signaling pathways. Br J Pharmacol. 2019;176(7):906–18.
19. Ma N, Liu X-W, Yang Y-J, Li J-Y, Mohamed I, Liu G-R, et al. Preventive effect of aspirin eugenol ester on thrombosis in κ-carrageenan-induced rat tail thrombosis model. PLoS One. 2015;10(7):e0133125.
20. da Silva FFM, Monte FJQ, de Lemos TLG, do Nascimento PGG, de Medeiros Costa AK, de Paiva LMM. Eugenol derivatives: synthesis, characterization, and evaluation of antibacterial and antioxidant activities. Chem Cent J [Internet]. 2018;12(1). Available from: http://dx.doi.org/10.1186/s13065-018-0407-4
21. Kim K, Park K-I. A review of antiplatelet activity of traditional medicinal herbs on integrative medicine studies. Evid Based Complement Alternat Med. 2019;2019:7125162.
22. Zhang C, Fan L, Fan S, Wang J, Luo T, Tang Y, et al. Cinnamomum cassia Presl: A review of its traditional uses, phytochemistry, pharmacology and toxicology. Molecules. 2019;24(19):3473.
23. globalnewscommunication. Riconoscimenti dal Mondo sulle ricerche del cardiologo italiano, Giampaolo Palma, su Malattia Coagulativa da Covid-19 [Internet]. Altervista.org. 2020 [cited 2021 May 16]. Available from: http://globalnewscommunication.altervista.org/2020/05/14/riconoscimenti-dal-mondo-sulle-ricerche-del-cardiologo-italiano-giampaolo-palma-su-malattia-coagulativa-da-covid-19/
24. Aiello V. Le autopsie (che il Ministero non voleva) rivelano la causa di morte dei pazienti con coronavirus [Internet]. Scienze fanpage. 2020 [cited 2021 May 18]. Available from: https://scienze.fanpage.it/le-autopsie-che-il-ministero-non-voleva-rivelano-la-causa-di-morte-dei-pazienti-con-coronavirus/
25. Singh NA, Kumar P, Jyoti, Kumar N. Spices and herbs: Potential antiviral preventives and immunity boosters during COVID-19. Phytother Res [Internet]. 2021;(ptr.7019). Available from: http://dx.doi.org/10.1002/ptr.7019
26. Parham S, Kharazi AZ, Bakhsheshi-Rad HR, Nur H, Ismail AF, Sharif S, et al. Antioxidant, antimicrobial and antiviral properties of herbal materials. Antioxidants (Basel). 2020;9(12):1309.
27. Goswami D, Kumar M, Ghosh SK, Das A. Natural Product Compounds in Alpinia officinarum and Ginger are Potent SARS-CoV-2 Papain-like Protease Inhibitors [Internet]. ChemRxiv. 2020. Available from: http://dx.doi.org/10.26434/chemrxiv.12071997
28. Plantsjournal.com. [cited 2021 May 15]. Available from: https://www.plantsjournal.com/archives/2018/vol6issue2/PartC/6-2-42-182.pdf
29. Tran HTT, Le NPK, Gigl M, Dawid C, Lamy E. Common dandelion (Taraxacum officinale) efficiently blocks the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614, mutants D614G, N501Y, K417N and E484K in vitro [Internet]. bioRxiv. 2021. Available from: http://dx.doi.org/10.1101/2021.03.19.435959
30. Virologyj.com. [cited 2021 May 15]. Available from: http://www.virologyj.com/content/8/1/538
31. Bitz B. Covid -19, Coronavirus: Herbal Classes based on the Viral Process [Internet]. Weeds & Wildflowers. 2020 [cited 2021 May 15]. Available from: https://medium.com/weeds-wildflowers/covid-19-coronavirus-potential-herbal-protocol-d06a43017ebe
32. Covid- 19: Coronavirus, potential herbal protocol - Google drive [Internet]. Google.com. [cited 2021 May 15]. Available from: https://docs.google.com/spreadsheets/d/e/2PACX-1vSU2F5ePoL1QFEZJx2N1BMESlZuQM5LoBdgtE2UTPlR2DohPy59RJ5ZySouoyAnpY3wWq1THMNwwxH4/pubhtml

Downloads

Published

2021-05-19

How to Cite

1.
Meyer Letona A, Columbié Pileta M, Piedrasanta AR. Fitoterapia de la Medicina Tradicional China para combatir de forma exitosa la covid-19. Rev. Cub. Tecnol. Salud. [Internet]. 2021 May 19 [cited 2025 May 23];12(2):117-28. Available from: https://revtecnologia.sld.cu/index.php/tec/article/view/2407

Issue

Vol. 12 No. 2 (2021): Abril-Junio

Section

Original Articles

License

Those authors who have publications with this journal accept the following terms:

The authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) that allows the use of the work to share (copy and redistribute the material in any medium or format) and adapt (remix, transform and build on the material) as long as mention is made of the publication in the journal as the primary source. However, you will not be able to trade with it.

The authors may adopt other non-exclusive license agreements for the distribution of the version of the published work (eg: deposit it in an institutional telematic file or preprint servers) provided that the initial publication in this journal is indicated.

The Cuban Health Technology Magazine is authorized by a Creative Commons Attribution-NonCommercial 4.0 International License.